| Jacob Clay O'neal, | |
|
9800 Shelard Pkwy Ste 115, Plymouth, MN 55441-6527 | |
| (763) 200-8900 | |
| Not Available |
| Full Name | Jacob Clay O'neal |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 9800 Shelard Pkwy Ste 115, Plymouth, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326747486 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Clay O'neal, 6139 W Arch Ave, Brown Deer, WI 53223-3461 Ph: (346) 273-6396 | Jacob Clay O'neal, 9800 Shelard Pkwy Ste 115, Plymouth, MN 55441-6527 Ph: (763) 200-8900 |
News Archive
Pioneering research into how our bodies manufacture the cells that make blood has moved us closer to regrowing tissues and organs. The findings also may let doctors grow the cells for transplantation into people to battle cancer, blood disorders and autoimmune diseases.
A high fat diet may kill regulatory T cells in the liver, allowing steatosis (simple fatty liver) to develop into steatohepatitis (fatty liver with inflammation), according to the results of a new study in the November issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).
Trius Therapeutics, Inc. announced that on February 26th, 2010, the FDA issued new draft guidance on non-inferiority clinical trials that will apply to the design of the Company's proposed Phase 3 trials for its investigational antibacterial drug torezolid phosphate.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
› Verified 9 days ago
Kya Rawn, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 2855 Campus Dr Ste 660, Plymouth, MN 55441 Phone: 612-439-9970 | |
Benjamin Monseth, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 12805 Highway 55 Ste 211, Plymouth, MN 55441 Phone: 763-550-9005 Fax: 763-559-2118 | |
Kaylie Broberg, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 9800 Shelard Pkwy Ste 115, Plymouth, MN 55441 Phone: 651-447-7507 Fax: 763-432-6001 | |
Rita Martin, LMFT-A, CCRC Couples Therapy Medicare: Medicare Enrolled Practice Location: 18205 45th Ave N Ste D, Plymouth, MN 55446 Phone: 214-554-4089 | |
Christena Marie Hermansen, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 10425 40th Ave N, Plymouth, MN 55441 Phone: 612-865-1169 | |
Benjamin Musburger, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 12805 Highway 55 Suite 206, Plymouth, MN 55441 Phone: 602-518-9921 | |
Jennifer Mcvann, MS, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3370 Annapolis Ln N Ste C, Plymouth, MN 55447 Phone: 952-270-3822 Fax: 612-235-6447 |